Epidemiology of Sarcoidosis: Recent Advances and Future Prospects

 

 Buy Article Permissions and Reprints

ABSTRACT

Sarcoidosis is by definition a disease of “unknown causes,” but recent epidemiologic advances suggest that the long-standing definition of sarcoidosis may soon need to be amended. The recently completed ACCESS (A Case-Control Etiologic Study of Sarcoidosis) study was not able to definitively identify the “cause” of sarcoidosis, but yielded important findings regarding familial and environmental risks that have advanced our understanding of this disease. The HLA-DRB1 associations reported in ACCESS along with the results of two recently completed genome scans of sarcoidosis in German Caucasians and African-Americans, respectively, have further defined the genetics of sarcoidosis. These studies suggest genetic heterogeneity of sarcoidosis risk between Caucasians and African-Americans and multiple susceptibility genes that interact together and with environmental factors in the disease pathogenesis. Genes that influence sarcoidosis clinical phenotypes may also be largely separate from sarcoidosis susceptibility genes. Although genetic studies of sarcoidosis in African-American populations are confounded by Caucasian admixture, this same admixture may be useful in identifying sarcoidosis genes linked with African ancestry. Case-only methods may be useful in identifying recent acute exposures linked to disease, genetic variants of risk, and gene-environment interactions. In summary, the epidemiology of sarcoidosis has a promising future that should eventually provide the answers to the etiologic origins of this complex disease.

REFERENCES

• 1 Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.  Am J Respir Crit Care Med. 1999;  160 736-755
  PubMedGoogle Scholar
• 2 ACCESS Group . Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group.  J Clin Epidemiol. 1999;  52 1173-1186
  CrossrefPubMedGoogle Scholar
• 3 Semenzato G. ACCESS: a case control etiologic study of sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 83-86
  PubMedGoogle Scholar
• 4 Rossman M D, Thompson B, Frederick M et al.. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.  Am J Hum Genet. 2003;  73 720-735
  CrossrefPubMedGoogle Scholar
• 5 Rybicki B A, Iannuzzi M C, Frederick M M et al.. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS).  Am J Respir Crit Care Med. 2001;  164 2085-2091
  CrossrefPubMedGoogle Scholar
• 6 Newman L S, Rose C S, Bresnitz E A et al.. A case control etiologic study of sarcoidosis: environmental and occupational risk factors.  Am J Respir Crit Care Med. 2004;  170 1324-1330
  CrossrefPubMedGoogle Scholar
• 7 Iannuzzi M C, Maliarik M J, Poisson L M, Rybicki B A. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African-Americans.  Am J Respir Crit Care Med. 2003;  167 1225-1231
  CrossrefPubMedGoogle Scholar
• 8 Valentonyte R, Hampe J, Huse K et al.. Sarcoidosis is associated with a truncating splice site mutation in BTNL2.  Nat Genet. 2005;  37 357-364
  CrossrefPubMedGoogle Scholar
• 9 Hizawa N, Yamaguchi E, Furuya K, Jinushi E, Ito A, Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population.  Am J Respir Crit Care Med. 1999;  159 2021-2023
  CrossrefPubMedGoogle Scholar
• 10 Rybicki B A, Walewski J L, Maliarik M J, Kian H, Iannuzzi M C. The BTNL2 gene and sarcoidosis susceptibility in African-Americans and whites.  Am J Hum Genet. 2005;  77 491-499
  CrossrefPubMedGoogle Scholar
• 11 Pandey J P, Frederick M. TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis.  Hum Immunol. 2002;  63 485-491
  CrossrefPubMedGoogle Scholar
• 12 Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide ( + 2763 G/A and + 2437 C/T) polymorphisms in sarcoidosis.  Int J Immunogenet. 2006;  33 135-140
  CrossrefPubMedGoogle Scholar
• 13 Dubaniewicz A, Jamieson S E, Dubaniewicz-Wybieralska M, Fakiola M, Nancy M E, Blackwell J M. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.  Eur J Hum Genet. 2005;  13 829-834
  CrossrefPubMedGoogle Scholar
• 14 Foley P J, Lympany P A, Puscinska E, Zielinski J, Welsh K I, du Bois R M. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis.  Am J Respir Crit Care Med. 1999;  160 1009-1014
  PubMedGoogle Scholar
• 15 Gazouli M, Koundourakis A, Ikonomopoulos J et al.. CARD15/NOD2, CD14, and Toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2006;  23 23-29
  PubMedGoogle Scholar
• 16 Zorzetto M, Bombieri C, Ferrarotti I et al.. Complement receptor 1 gene polymorphisms in sarcoidosis.  Am J Respir Cell Mol Biol. 2002;  27 17-23
  PubMedGoogle Scholar
• 17 Takada T, Suzuki E, Morohashi K, Gejyo F. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population.  Tissue Antigens. 2002;  60 36-42
  CrossrefPubMedGoogle Scholar
• 18 Akahoshi M, Ishihara M, Remus N et al.. Association between IFNA genotype and the risk of sarcoidosis.  Hum Genet. 2004;  114 503-509
  CrossrefPubMedGoogle Scholar
• 19 Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis.  Chest. 2003;  123 1520-1526
  CrossrefPubMedGoogle Scholar
• 20 Rybicki B A, Major M, Popovich J J, Maliarik M J, Iannuzzi M C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.  Am J Epidemiol. 1997;  145 234-241
  CrossrefPubMedGoogle Scholar
• 21 Yamaguchi M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan: recent trends in incidence and prevalence rates and changes in epidemiological features.  Sarcoidosis. 1989;  6 138-146
  PubMedGoogle Scholar
• 22 Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study.  Am Rev Respir Dis. 1984;  130 29-32
  PubMedGoogle Scholar
• 23 Henke C E, Henke G, Elveback L R, Beard C M, Ballard D J, Kurland L T. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival.  Am J Epidemiol. 1986;  123 840-845
  PubMedGoogle Scholar
• 24 Byg K E, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994: a registry-based incidence study comprising 5536 patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 46-52
  PubMedGoogle Scholar
• 25 Furuya K, Yamaguchi E, Itoh A et al.. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.  Thorax. 1996;  51 777-780
  CrossrefPubMedGoogle Scholar
• 26 Kruit A, Ruven H J, Grutters J C, Van Den Bosch J M. Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 195-203
  PubMedGoogle Scholar
• 27 Rybicki B A, Kirkey K L, Major M et al.. Familial risk ratio of sarcoidosis in African-American sibs and parents.  Am J Epidemiol. 2001;  153 188-193
  CrossrefPubMedGoogle Scholar
• 28 Baughman R P, Teirstein A S, Judson M A et al.. Clinical characteristics of patients in a case control study of sarcoidosis.  Am J Respir Crit Care Med. 2001;  164 1885-1889
  CrossrefPubMedGoogle Scholar
• 29 Judson M A, Baughman R P, Thompson B W et al.. Two year prognosis of sarcoidosis: the ACCESS experience.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 204-211
  PubMedGoogle Scholar
• 30 Terris M, Chavis A D. An epidemiologic study of sarcoidosis.  Am Rev Respir Dis. 1966;  94 50-55
  PubMedGoogle Scholar
• 31 Buck A A, Sartwell P E. Epidemiologic investigations of sarcoidosis, II: Skin sensitivity and environmental factors.  Am J Hyg. 1961;  74 152-173
  PubMedGoogle Scholar
• 32 Cummings M M, Hudgins P C. Chemical constituents of pine pollen and their possible relationship to sarcoidosis.  Am J Med Sci. 1958;  236 311-317
  PubMedGoogle Scholar
• 33 Burdick K H. Cutaneous reaction to pine pollen in sarcoidosis: study of forty cases.  J Invest Dermatol. 1964;  42 449-451
  PubMedGoogle Scholar
• 34 Gentry J T, Nitowsky H M, Michael Jr M. Studies on the epidemiology of sarcoidosis in the United States: the relationship to soil areas and to urban-rural residence.  J Clin Invest. 1955;  34 1839-1856
  PubMedGoogle Scholar
• 35 Comstock G W, Keltz H, Sencer J. Clay eating and sarcoidosis: a controlled study in the state of Georgia.  Am Rev Respir Dis. 1961;  84 130-134
  PubMedGoogle Scholar
• 36 Hurley H J, Close H P, English R S. Soil extracts as antigens in sarcoidosis.  Am Rev Respir Dis. 1962;  86 100-102
  PubMedGoogle Scholar
• 37 Kajdasz D K, Lackland D T, Mohr L C, Judson M A. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis.  Ann Epidemiol. 2001;  11 111-117
  CrossrefPubMedGoogle Scholar
• 38 Drent M, Bomans P H, Van Suylen R J, Lamers R J, Bast A, Wouters E F. Association of man-made mineral fibre exposure and sarcoidlike granulomas.  Respir Med. 2000;  94 815-820
  CrossrefPubMedGoogle Scholar
• 39 Rafnsson V, Ingimarsson O, Hjalmarsson I, Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis.  Occup Environ Med. 1998;  55 657-660
  CrossrefPubMedGoogle Scholar
• 40 Rybicki B A, Amend K L, Maliarik M J, Iannuzzi M C. Photocopier exposure and risk of sarcoidosis in African-American sibs.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 49-55
  PubMedGoogle Scholar
• 41 Kucera G P, Rybicki B A, Kirkey K L et al.. Occupational risk factors for sarcoidosis in African-American siblings.  Chest. 2003;  123 1527-1535
  CrossrefPubMedGoogle Scholar
• 42 Gorham E D, Garland C F, Garland F C, Kaiser K, Travis W D, Centeno J A. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in navy personnel: a 27-year historical prospective study, 1975-2001.  Chest. 2004;  126 1431-1438
  CrossrefPubMedGoogle Scholar
• 43 Barnard J, Rose C, Newman L et al.. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (ACCESS).  J Occup Environ Med. 2005;  47 226-234
  CrossrefPubMedGoogle Scholar
• 44 Prezant D J, Dhala A, Goldstein A et al.. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters.  Chest. 1999;  116 1183-1193
  CrossrefPubMedGoogle Scholar
• 45 Kern D G, Neill M A, Wrenn D S, Varone J C. Investigation of a unique time-space cluster of sarcoidosis in firefighters.  Am Rev Respir Dis. 1993;  148 974-980
  CrossrefPubMedGoogle Scholar
• 46 Falkinham III J O. Mycobacterial aerosols and respiratory disease.  Emerg Infect Dis. 2003;  9 763-767
  PubMedGoogle Scholar
• 47 Fite E, Fernandez-Figueras M T, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain.  Respiration. 2006;  73 20-26
  CrossrefPubMedGoogle Scholar
• 48 Vokurka M, Lecossier D, du Bois R M et al.. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis.  Am J Respir Crit Care Med. 1997;  156 1000-1003
  PubMedGoogle Scholar
• 49 Brown S T, Brett I, Almenoff P L, Lesser M, Terrin M, Teirstein A S. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects.  Chest. 2003;  123 413-417
  CrossrefPubMedGoogle Scholar
• 50 du Bois R M, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis?.  J Intern Med. 2003;  253 4-17
  CrossrefPubMedGoogle Scholar
• 51 Drake W P, Newman L S. Mycobacterial antigens may be important in sarcoidosis pathogenesis.  Curr Opin Pulm Med. 2006;  12 359-363
  CrossrefPubMedGoogle Scholar
• 52 Buck A A, McKusick V A. Epidemiologic investigations of sarcoidosis, III: Serum proteins, syphilis, association with tuberculosis: familial aggregation.  Am J Hyg. 1961;  74 174-188
  PubMedGoogle Scholar
• 53 Headings V E, Weston D, Young R CJ, Hackney R LJ. Familial sarcoidosis with multiple occurrences in eleven families: a possible mechanism of inheritance.  Ann NY Acad Sci. 1976;  278 377-385
  CrossrefPubMedGoogle Scholar
• 54 McGrath D S, Daniil Z, Foley P et al.. Epidemiology of familial sarcoidosis in the UK.  Thorax. 2000;  55 751-754
  CrossrefPubMedGoogle Scholar
• 55 Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Müller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis.  Am J Respir Crit Care Med. 2001;  164 840-846
  CrossrefPubMedGoogle Scholar
• 56 Rybicki B A, Hirst K, Iyengar S K et al.. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 115-122
  PubMedGoogle Scholar
• 57 Haseman J K, Elston R C. The investigation of linkage between a quantitative trait and marker locus.  Behav Genet. 1972;  2 3-19
  CrossrefPubMedGoogle Scholar
• 58 Iannuzzi M C, Iyengar S K, Gray-McGuire C et al.. Genome-wide search for sarcoidosis susceptibility genes in African-Americans.  Genes Immun. 2005;  6 509-518
  CrossrefPubMedGoogle Scholar
• 59 Gray-McGuire C, Sinha R, Iyengar S et al.. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African-Americans on chromosome 5.  Hum Genet. , In press
  PubMedGoogle Scholar
• 60 Thompson C L, Rybicki B A, Iannuzzi M C et al.. Reduction of sample heterogeneity through use of population substructure: an example from a population of African-American families with sarcoidosis.  Am J Hum Genet. 2006;  79 606-613
  CrossrefPubMedGoogle Scholar
• 61 Petrek M, Drabek J, Kolek V et al.. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis.  Am J Respir Crit Care Med. 2000;  162 1000-1003
  CrossrefPubMedGoogle Scholar
• 62 Spagnolo P, Renzoni E A, Wells A U et al.. C-C chemokine receptor 2 and sarcoidosis: association with Löfgren's syndrome.  Am J Respir Crit Care Med. 2003;  168 1162-1166
  CrossrefPubMedGoogle Scholar
• 63 Valentonyte R, Hampe J, Croucher PJ, et al.. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family based analysis.  Am J Respir Crit Care Med. 2005;  11 1136-1141
  PubMedGoogle Scholar
• 64 Li Y, Wollnik B, Pabst S et al.. BTNL2 gene variant and sarcoidosis.  Thorax. 2006;  61 273-274
  CrossrefPubMedGoogle Scholar
• 65 Brewerton D A, Cockburn C, James D C, James D G, Neville E. HLA antigens in sarcoidosis.  Clin Exp Immunol. 1977;  27 227-229
  PubMedGoogle Scholar
• 66 Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis.  Tissue Antigens. 1983;  22 200-203
  CrossrefPubMedGoogle Scholar
• 67 Mrazek F, Holla L I, Hutyrova B et al.. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.  Tissue Antigens. 2005;  65 163-171
  CrossrefPubMedGoogle Scholar
• 68 Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.  Am J Respir Crit Care Med. 1997;  156 1601-1605
  CrossrefPubMedGoogle Scholar
• 69 Swider C, Schnittger L, Bogunia-Kubik K et al.. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis.  Eur Cytokine Netw. 1999;  10 143-146
  PubMedGoogle Scholar
• 70 Sato H, Grutters J C, Pantelidis P et al.. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.  Am J Respir Cell Mol Biol. 2002;  27 406-412
  CrossrefPubMedGoogle Scholar
• 71 Lofgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases.  Acta Med Scand. 1946;  124 1-197
  PubMedGoogle Scholar
• 72 Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients.  Am J Respir Crit Care Med. 2004;  169 696-702
  CrossrefPubMedGoogle Scholar
• 73 Martinetti M, Tinelli C, Kolek V et al.. “The sarcoidosis map”: a joint survey of clinical and immunogenetic findings in two European countries.  Am J Respir Crit Care Med. 1995;  152 557-564
  PubMedGoogle Scholar
• 74 Papadopoulos K I, Melander O, Orho-Melander M, Groop L C, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases.  J Intern Med. 2000;  247 71-77
  CrossrefPubMedGoogle Scholar
• 75 Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients.  Eur Respir J. 1999;  13 723-726
  CrossrefPubMedGoogle Scholar
• 76 Maliarik M J, Rybicki B A, Malvitz E et al.. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis.  Am J Respir Crit Care Med. 1998;  158 1566-1570
  PubMedGoogle Scholar
• 77 Niimi T, Tomita H, Sato S et al.. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients.  Chest. 1998;  114 495-499
  PubMedGoogle Scholar
• 78 Ohchi T, Shijubo N, Kawabata I et al.. Polymorphism of Clara cell 10-kD protein gene of sarcoidosis.  Am J Respir Crit Care Med. 2004;  169 180-186
  PubMedGoogle Scholar
• 79 Janssen R, Sato H, Grutters J C et al.. The Clara cell10 adenine38guanine polymorphism and sarcoidosis susceptibility in Dutch and Japanese subjects.  Am J Respir Crit Care Med. 2004;  170 1185-1187
  CrossrefPubMedGoogle Scholar
• 80 Hattori N, Niimi T, Sato S et al.. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 27-32
  PubMedGoogle Scholar
• 81 Naruse T K, Matsuzawa Y, Ota M et al.. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis.  Tissue Antigens. 2000;  56 52-57
  CrossrefPubMedGoogle Scholar
• 82 Voorter C E, Drent M, van den Berg-Loonen E M. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101.  Hum Immunol. 2005;  66 826-835
  CrossrefPubMedGoogle Scholar
• 83 Sharma S K, Balamurugan A, Pandey R M, Saha P K, Mehra N K. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians.  Am J Respir Cell Mol Biol. 2003;  29 225-231
  CrossrefPubMedGoogle Scholar
• 84 Grutters J C, Sato H, Pantelidis P et al.. Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 20-27
  PubMedGoogle Scholar
• 85 Abdallah A, Sato H, Grutters J C et al.. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis.  Genes Immun. 2003;  4 450-454
  CrossrefPubMedGoogle Scholar
• 86 Hill M R, Papafili A, Booth H et al.. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis.  Am J Respir Crit Care Med. 2006;  174 915-922
  CrossrefPubMedGoogle Scholar
• 87 Pabst S, Baumgarten G, Stremmel A et al.. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis.  Clin Exp Immunol. 2006;  143 420-426
  CrossrefPubMedGoogle Scholar
• 88 Grutters J C, Sato H, Pantelidis P et al.. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis.  Am J Respir Crit Care Med. 2002;  165 1119-1124
  CrossrefPubMedGoogle Scholar
• 89 Labunski S, Posern G, Ludwig S, Kundt G, Brocker E B, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.  Acta Derm Venereol. 2001;  81 18-21
  PubMedGoogle Scholar
• 90 Takashige N, Naruse T K, Matsumori A et al.. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis.  Tissue Antigens. 1999;  54 191-193
  CrossrefPubMedGoogle Scholar
• 91 Seitzer U, Swider C, Stuber F et al.. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.  Cytokine. 1997;  9 787-790
  CrossrefPubMedGoogle Scholar
• 92 Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis.  Chest. 2001;  119 753-761
  CrossrefPubMedGoogle Scholar
• 93 Kreider M E, Christie J D, Thompson B et al.. Relationship of environmental exposures to the clinical phenotype of sarcoidosis.  Chest. 2005;  128 207-215
  CrossrefPubMedGoogle Scholar
• 94 Grutters J C, Sato H, Welsh K I, du Bois R M. The importance of sarcoidosis genotype to lung phenotype.  Am J Respir Cell Mol Biol. 2003;  29 S59-S62
  PubMedGoogle Scholar
• 95 Yamada R, Ymamoto K. Recent findings on genes associated with inflammatory disease.  Mutat Res. 2005;  573 136-151
  PubMedGoogle Scholar
• 96 Rybicki B A, Sinha R, Iyengar S, Gray-McGuire C, Elston R C, Iannuzzi M C. SAGA Study Consortium . Genetic linkage analysis of sarcoidosis phenotypes: the Sarcoidosis Genetic Analysis (SAGA) Study.  Genet Immun. In press.
  PubMedGoogle Scholar
• 97 Hills S E, Parkes S A, Baker S B. Epidemiology of sarcoidosis in the Isle of Man, II: Evidence for space-time clustering.  Thorax. 1987;  42 427-430
  PubMedGoogle Scholar
• 98 Edmondstone W M, Wilson A G. Temporal clustering of familial sarcoidosis in non-consanguineous relatives.  Br J Dis Chest. 1984;  78 184-186
  PubMedGoogle Scholar
• 99 Visser H, Vos K, Zanelli E et al.. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.  Ann Rheum Dis. 2002;  61 499-504
  CrossrefPubMedGoogle Scholar
• 100 Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events.  Am J Epidemiol. 1991;  133 144-153
  CrossrefPubMedGoogle Scholar
• 101 Wacholder S, Hartge P, Struewing J P et al.. The kin-cohort study for estimating penetrance.  Am J Epidemiol. 1998;  148 623-630
  PubMedGoogle Scholar
• 102 Saunders C L, Begg C B. Kin-cohort evaluation of relative risks of genetic variants.  Genet Epidemiol. 2003;  24 220-229
  CrossrefPubMedGoogle Scholar
• 103 Gail M H, Pee D, Carroll R. Kin-cohort designs for gene characterization.  J Natl Cancer Inst Monogr. 1999;  55-60
  PubMedGoogle Scholar
• 104 Rybicki B A, Elston R C. The relationship between the sibling recurrence-risk ratio and genotype relative risk.  Am J Hum Genet. 2000;  66 593-604
  CrossrefPubMedGoogle Scholar
• 105 Umbach D M, Weinberg C R. Designing and analysing case-control studies to exploit independence of genotype and exposure.  Stat Med. 1997;  16 1731-1743
  CrossrefPubMedGoogle Scholar
• 106 Khoury M J, Flanders W D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!.  Am J Epidemiol. 1996;  144 207-213
  PubMedGoogle Scholar
• 107 Albert P S, Ratnasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions.  Am J Epidemiol. 2001;  154 687-693
  CrossrefPubMedGoogle Scholar
• 108 Gatto N M, Campbell U B, Rundle A G, Ahsan H. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias.  Int J Epidemiol. 2004;  33 1014-1024
  CrossrefPubMedGoogle Scholar
• 109 Gundelfinger B F, Britten S A. Sarcoidosis in the United States Navy.  Am Rev Respir Dis. 1961;  84(suppl) 109-115
  PubMedGoogle Scholar
• 110 Sartwell P E, Edwards L B. Epidemiology of sarcoidosis in the US Navy.  Am J Epidemiol. 1974;  99 250-257
  PubMedGoogle Scholar
• 111 Benatar S R. Sarcoidosis in South Africa: a comparative study in whites, blacks and coloureds.  S Afr Med J. 1977;  52 602-606
  PubMedGoogle Scholar
• 112 Edmondstone W M, Wilson A G. Sarcoidosis in Caucasians, blacks and Asians in London.  Br J Dis Chest. 1985;  79 27-36
  CrossrefPubMedGoogle Scholar
• 113 Parra E J, Marcini A, Akey J et al.. Estimating African-American admixture proportions by use of population-specific alleles.  Am J Hum Genet. 1998;  63 1839-1851
  CrossrefPubMedGoogle Scholar
• 114 McKeigue P M, Carpenter J R, Parra E J, Shriver M D. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations.  Ann Hum Genet. 2000;  64 171-186
  CrossrefPubMedGoogle Scholar
• 115 Smith M W, O'Brien S J. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines.  Nat Rev Genet. 2005;  6 623-632
  CrossrefPubMedGoogle Scholar
• 116 Stephens J C, Briscoe D, O'Brien S J. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines.  Am J Hum Genet. 1994;  55 809-824
  PubMedGoogle Scholar
• 117 Rybicki B A, Iyengar S K, Harris T et al.. The distribution of long range admixture linkage disequilibrium in an African-American population.  Hum Hered. 2002;  53 187-196
  CrossrefPubMedGoogle Scholar
• 118 Tian C, Hinds D A, Shigeta R, Kittles R, Ballinger D G, Seldin M FA. Genome-wide SNP panel with high ancestry information for African-American admixture mapping.  Am J Hum Genet. 2006;  79 640-649
  CrossrefPubMedGoogle Scholar
• 119 Smith M W, Patterson N, Lautenberger J A et al.. A high-density admixture map for disease gene discovery in African-Americans.  Am J Hum Genet. 2004;  74 1001-1013
  CrossrefPubMedGoogle Scholar
• 120 Collins F S, McKusick V A. Implications of the Human Genome Project for medical science.  JAMA. 2001;  285 540-544
  CrossrefPubMedGoogle Scholar

Benjamin A RybickiPh.D. 

Department of Biostatistics and Research Epidemiology

Henry Ford Health System, Detroit, MI 48202

Email: brybick1@hfhs.org